CZ307395A3 - Arylation agents, pharmaceutical compositions containing thereof and their use - Google Patents
Arylation agents, pharmaceutical compositions containing thereof and their use Download PDFInfo
- Publication number
- CZ307395A3 CZ307395A3 CZ953073A CZ307395A CZ307395A3 CZ 307395 A3 CZ307395 A3 CZ 307395A3 CZ 953073 A CZ953073 A CZ 953073A CZ 307395 A CZ307395 A CZ 307395A CZ 307395 A3 CZ307395 A3 CZ 307395A3
- Authority
- CZ
- Czechia
- Prior art keywords
- acid
- group
- compound
- nitro
- chloro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/06—Phenols the aromatic ring being substituted by nitro groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/06—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
- C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
- C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
- C07C205/20—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings
- C07C205/21—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C205/24—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring having three, and only three, nitro groups bound to the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/58—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/52—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/39—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing halogen atoms bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/40—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitro or nitroso groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/46—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/68—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
- C07C63/70—Monocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939310520A GB9310520D0 (en) | 1993-05-21 | 1993-05-21 | Arylating agents |
GB9405292A GB9405292D0 (en) | 1993-05-21 | 1994-03-17 | Arylating agents |
Publications (1)
Publication Number | Publication Date |
---|---|
CZ307395A3 true CZ307395A3 (en) | 1996-06-12 |
Family
ID=26302926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CZ953073A CZ307395A3 (en) | 1993-05-21 | 1994-05-23 | Arylation agents, pharmaceutical compositions containing thereof and their use |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0700287A1 (xx) |
JP (1) | JPH08510468A (xx) |
CN (1) | CN1124012A (xx) |
AP (1) | AP9400647A0 (xx) |
AU (1) | AU6729794A (xx) |
BG (1) | BG100242A (xx) |
BR (1) | BR9406548A (xx) |
CA (1) | CA2163459A1 (xx) |
CZ (1) | CZ307395A3 (xx) |
DZ (1) | DZ1781A1 (xx) |
FI (1) | FI955605A (xx) |
HU (1) | HUT77764A (xx) |
IL (1) | IL109712A0 (xx) |
MA (1) | MA23202A1 (xx) |
NO (1) | NO954702L (xx) |
OA (1) | OA10196A (xx) |
SK (1) | SK145795A3 (xx) |
WO (1) | WO1994027584A2 (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1900195A (en) * | 1994-03-17 | 1995-10-03 | Radopath Limited | Anti-viral and anti-cancer agents |
GB2303790A (en) * | 1994-03-17 | 1997-03-05 | Radopath Ltd | Benzoic acid containing chloro and or nitro groups for cancer or viral therapy |
AU5115396A (en) * | 1995-03-17 | 1996-10-08 | Radopath Limited | Anti-viral and anti-cancer agents |
EP0817623B1 (de) * | 1995-03-30 | 2003-11-12 | Werner Prof. Dr. Kreutz | Arzneistoffe zur selektiven bekämpfung von tumorgewebe |
US5756548A (en) * | 1995-04-03 | 1998-05-26 | Centaur Pharmaceuticals, Inc. | Acetamidobenzamide compounds for neurodegenerative disorders |
GB9615619D0 (en) * | 1996-03-18 | 1996-09-04 | Radopath Ltd | Costimulation of TcR/CD3-induced T-Lymphocytes |
US5955506A (en) * | 1996-04-03 | 1999-09-21 | Centaur Pharmaceuticals, Inc. | Benzamides for neurodegenerative disorder treatment |
WO2007011962A2 (en) | 2005-07-18 | 2007-01-25 | Bipar Sciences, Inc. | Treatment of cancer |
US8143447B2 (en) | 2006-09-05 | 2012-03-27 | Bipar Sciences, Inc. | Treatment of cancer |
EP2217227B1 (en) | 2007-11-12 | 2013-08-21 | BiPar Sciences, Inc. | Treatment of breast cancer with 4-iodo-3-nitrobenzamide in combination with anti-tumor agents |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1283331A (en) * | 1970-01-03 | 1972-07-26 | Smith Kline French Lab | Pharmaceutical compositions |
US3978119A (en) * | 1975-07-11 | 1976-08-31 | Gulf Research & Development Company | Process for converting stilbene or bibenzyl to nitrobenzoic acids |
US4283421A (en) * | 1979-12-19 | 1981-08-11 | Ray Frank F | Anti-viral treatment |
US4277492A (en) * | 1980-05-21 | 1981-07-07 | The Dow Chemical Company | Novel 4-bis((Phenylmethyl)amino)-benzenesulfonic acids possessing antiviral activity |
US4762705A (en) * | 1981-11-10 | 1988-08-09 | Adolf W. Schwimmer | Cancer therapy with interferon |
CA1262864A (en) * | 1982-09-17 | 1989-11-14 | Clarence D. Cone | Method for producing oncolysis |
US4935450A (en) * | 1982-09-17 | 1990-06-19 | Therapeutical Systems Corporation | Cancer therapy system for effecting oncolysis of malignant neoplasms |
JPS60224619A (ja) * | 1984-04-24 | 1985-11-09 | Adeka Argus Chem Co Ltd | 放射線増感剤 |
RO92333B1 (ro) * | 1985-06-18 | 1987-09-01 | Institutul De Cercetari Chimico-Farmaceutice | Produs radiosensibilizator al celulelor tumorale |
JPS6468315A (en) * | 1987-09-09 | 1989-03-14 | Yasuo Kawasaki | Antipyrotic of picric acid (2,4,6-trinitrophenol) |
WO1991011117A2 (en) * | 1990-02-05 | 1991-08-08 | Board Of Regents, The University Of Texas System | Dietary supplements comprising vitamins and minerals |
CA2036695A1 (en) * | 1990-03-01 | 1991-09-02 | Brian Gregory Chapman | Solid imaging apparatus and method with coating station |
GB9103075D0 (en) * | 1991-02-13 | 1991-03-27 | Washington Odur Ayuko | Trinitrobenzene derivatives and their therapeutic use |
JPH06501449A (ja) * | 1990-04-03 | 1994-02-17 | ラドパス リミテッド | 癌またはウイル性疾患の治療におけるトリニトロベンゼン類またはカルミン酸の使用 |
US5422277A (en) * | 1992-03-27 | 1995-06-06 | Ortho Diagnostic Systems Inc. | Cell fixative composition and method of staining cells without destroying the cell surface |
-
1994
- 1994-05-18 DZ DZ940047A patent/DZ1781A1/fr active
- 1994-05-20 MA MA23512A patent/MA23202A1/fr unknown
- 1994-05-20 AP APAP/P/1994/000647A patent/AP9400647A0/en unknown
- 1994-05-22 IL IL10971294A patent/IL109712A0/xx unknown
- 1994-05-23 CZ CZ953073A patent/CZ307395A3/cs unknown
- 1994-05-23 HU HU9503327A patent/HUT77764A/hu unknown
- 1994-05-23 EP EP94915671A patent/EP0700287A1/en not_active Ceased
- 1994-05-23 AU AU67297/94A patent/AU6729794A/en not_active Abandoned
- 1994-05-23 JP JP7500384A patent/JPH08510468A/ja active Pending
- 1994-05-23 CA CA002163459A patent/CA2163459A1/en not_active Abandoned
- 1994-05-23 SK SK1457-95A patent/SK145795A3/sk unknown
- 1994-05-23 BR BR9406548A patent/BR9406548A/pt not_active Application Discontinuation
- 1994-05-23 WO PCT/GB1994/001126 patent/WO1994027584A2/en not_active Application Discontinuation
- 1994-05-23 CN CN94192181A patent/CN1124012A/zh active Pending
-
1995
- 1995-11-21 OA OA60743A patent/OA10196A/en unknown
- 1995-11-21 FI FI955605A patent/FI955605A/fi not_active Application Discontinuation
- 1995-11-21 NO NO954702A patent/NO954702L/no unknown
- 1995-12-21 BG BG100242A patent/BG100242A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
BR9406548A (pt) | 1996-01-02 |
OA10196A (en) | 1996-12-18 |
JPH08510468A (ja) | 1996-11-05 |
AU6729794A (en) | 1994-12-20 |
FI955605A (fi) | 1996-01-22 |
SK145795A3 (en) | 1996-10-02 |
IL109712A0 (en) | 1994-08-26 |
WO1994027584A3 (en) | 1995-05-26 |
NO954702D0 (no) | 1995-11-21 |
EP0700287A1 (en) | 1996-03-13 |
BG100242A (bg) | 1996-07-31 |
WO1994027584A2 (en) | 1994-12-08 |
AP9400647A0 (en) | 1995-11-20 |
HU9503327D0 (en) | 1996-01-29 |
DZ1781A1 (fr) | 2002-02-17 |
NO954702L (no) | 1996-01-22 |
CA2163459A1 (en) | 1994-12-08 |
HUT77764A (hu) | 1998-08-28 |
CN1124012A (zh) | 1996-06-05 |
MA23202A1 (fr) | 1994-12-31 |
FI955605A0 (fi) | 1995-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CZ307395A3 (en) | Arylation agents, pharmaceutical compositions containing thereof and their use | |
US6703382B2 (en) | Small molecule inhibitors targeted at Bcl-2 | |
CA1175047A (en) | Xanthates | |
US5679695A (en) | Aryl and heteroaryl compounds having anti-retrovirus activity | |
PL189618B1 (pl) | Kompozycje przeciwwirusowe i przeciwzapalne oraz zastosowanie tych kompozycji | |
JP5770098B2 (ja) | 脳卒中治療剤の製造におけるピノセンブリンラセミ化合物の使用 | |
JP2009539838A5 (xx) | ||
EP1289513B1 (en) | Use of aloe-emodin in the treatment of neuroectodermal tumors | |
JPH0714875B2 (ja) | ウイルス阻害医薬組成物 | |
GB2312375A (en) | Therapeutic arylating agents | |
DE60210504T2 (de) | Funktionalisierte höhere diamantoide | |
LT3609B (en) | Arylating agents, used in the treatment of cancerand disease caused by viral infection | |
AP575A (en) | Anti viral and anti cancer agents. | |
KR970005329B1 (ko) | 포유 동물의 레트로바이러스 감염 치료용 조성물 | |
WO1996000067A1 (en) | Inhibitor | |
JP2007523193A (ja) | 膵癌の治療のためのβ−ラパコンの使用 | |
US20220175937A1 (en) | Selected artemisinin dimers for the treatment of lashmaniasis | |
GB2303790A (en) | Benzoic acid containing chloro and or nitro groups for cancer or viral therapy | |
EP0902683A1 (en) | AGONISTS IN THE COSTIMULATION OF TcR/CD3-INDUCED T-LYMPHOCYTES | |
WO1989009056A1 (en) | Antiviral composition containing aromatic polycyclic diones and nucleoside analogs and method for treating retrovirus infections | |
GB2155014A (en) | Aminodiaryl sulfoxide derivatives | |
WO2020125911A1 (es) | Lactonas sesquiterpenicas de koanophyllon gibbosum, y su uso para el tratamiento de distintos tipos de cancer | |
ES2653674A1 (es) | Aminas derivadas de 5- Nitroindazol con propiedades antiprotozoarias | |
HU192292B (en) | Process for preparing substituted salicylic acid amides and pharmaceutical compositions containing such compounds | |
Kayserl et al. | Albany, NY 12201-2002, USA |